A Next-Generation Risk Assessment Case Study for Coumarin in Cosmetic Products
Open accessThe DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Abstract
Next-Generation Risk Assessment is defined as an exposure-led, hypothesis-driven risk assessment approach that integrates new approach methodologies (NAMs) to assure safety without the use of animal testing. These principles were applied to a hypothetical safety assessment of 0.1% coumarin in face cream and body lotion. For the purpose of evaluating the use of NAMs, existing animal and human data on coumarin were excluded. Internal concentrations (plasma Cmax) were estimated using a physiologically based kinetic model for dermally applied coumarin. Systemic toxicity was assessed using a battery of in vitro NAMs to identify points of departure (PoDs) for a variety of biological effects such as receptor-mediated and immunomodulatory effects (Eurofins SafetyScreen44 and BioMap Diversity 8 Panel, respectively), and general bioactivity (ToxCast data, an in vitro cell stress panel and high-throughput transcriptomics). In addition, in silico alerts for genotoxicity were followed up with the ToxTracker tool. The PoDs from the in vitro assays were plotted against the calculated in vivo exposure to calculate a margin of safety with associated uncertainty. The predicted Cmax values for face cream and body lotion were lower than all PoDs with margin of safety higher than 100. Furthermore, coumarin was not genotoxic, did not bind to any of the 44 receptors tested and did not show any immunomodulatory effects at consumer-relevant exposures. In conclusion, this case study demonstrated the value of integrating exposure science, computational modeling and in vitro bioactivity data, to reach a safety decision without animal data.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2
Love, M. I., Huber, W., & Anders, S. (2014) · Genome Biology · doi:10.1186/s13059-014-0550-8 · Cited by 95,106
Schurch, N. J., Schofield, P., Gierliński, M., Cole, C., Sherstnev, A., Singh, V., Wrobel, N., Gharbi, K., Simpson, G. G., Owen-Hughes, T., et al. (2016) · RNA · doi:10.1261/rna.053959.115 · Cited by 966
Reducing safety-related drug attrition: the use of in vitro pharmacological profiling
Bowes, J., Brown, A. J., Hamon, J., Jarolimek, W., Sridhar, A., Waldron, G., & Whitebread, S. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3845 · Cited by 748 · cited 1×
“The SafetyScreen44 panel includes 44 targets associated with in vivo adverse drug reactions (Bowes et al., 2012).”
BackgroundJones, H., Chen, Y., Gibson, C., Heimbach, T., Parrott, N., Peters, S., Snoeys, J., Upreti, V., Zheng, M., & Hall, S. (2015) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.37 · Cited by 488 · cited 1×
“ceutical development (Jones et al., 2015), there are still issues”
Predicting Clearance Mechanism in Drug Discovery: Extended Clearance Classification System (ECCS)
Varma, M. V., Steyn, S. J., Allerton, C., & El-Kattan, A. F. (2015) · Pharmaceutical Research · doi:10.1007/s11095-015-1749-4 · Cited by 334
Toxicology and risk assessment of coumarin: Focus on human data
Abraham, K., Wöhrlin, F., Lindtner, O., Heinemeyer, G., & Lampen, A. (2010) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.200900281 · Cited by 292
Yokoyama, Y., Sasaki, Y., Terasaki, N., Kawataki, T., Takekawa, K., Iwase, Y., Shimizu, T., Sanoh, S., & Ohta, S. (2018) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b17-00913 · Cited by 160
Kramer, N. I., Krismartina, M., Rico-Rico, Á., Blaauboer, B. J., & Hermens, J. L. M. (2012) · Chemical Research in Toxicology · doi:10.1021/tx200479k · Cited by 156
Adeleye, Y., Andersen, M., Clewell, R., Davies, M., Dent, M., Edwards, S., Fowler, P., Malcomber, S., Nicol, B., Scott, A., et al. (2015) · Toxicology · doi:10.1016/j.tox.2014.02.007 · Cited by 127
Self-citationPredicting Drug-Induced Liver Injury with Bayesian Machine Learning
Williams, D. P., Lazic, S. E., Foster, A. J., Semenova, E., & Morgan, P. (2020) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.9b00264 · Cited by 124
Cited by
New approach methodologies in human regulatory toxicology – Not if, but how and when!
Schmeisser, S., Miccoli, A., von Bergen, M., Berggren, E., Braeuning, A., Busch, W., Desaintes, C., Gourmelon, A., Grafström, R., Harrill, J., et al. (2023) · Environment International · doi:10.1016/j.envint.2023.108082 · Cited by 380
New approach methodologies (NAMs): identifying and overcoming hurdles to accelerated adoption
Sewell, F., Alexander-White, C., Brescia, S., Currie, R. A., Roberts, R., Roper, C., Vickers, C., Westmoreland, C., & Kimber, I. (2024) · Toxicology Research · doi:10.1093/toxres/tfae044 · Cited by 213
“There are also well-documented examples of NAMs used in individual risk assessments both within the consumer goods industry (e.g. coumarin 36 ; phenoxyethanol 37 ; benzophenone-4 38 ) and within other sectors (e.g. chlorothalonil, 39 Captan and Folpet 12,40 ).”
BackgroundSelf-citationNyffeler, J., Willis, C., Harris, F. R., Foster, M. J., Chambers, B., Culbreth, M., Brockway, R. E., Davidson-Fritz, S., Dawson, D., Shah, I., et al. (2023) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2023.116513 · Cited by 67
Current opinion on risk assessment of cosmetics
Kim, K.-B., Kwack, S. J., Lee, J. Y., Kacew, S., & Lee, B.-M. (2021) · Journal of Toxicology and Environmental Health Part B · doi:10.1080/10937404.2021.1907264 · Cited by 63
“test similar to the NOAEL used in animal experiments (Baltazar et al. 2020).”
MethodMicrophysiological Systems Evaluation: Experience of TEX-VAL Tissue Chip Testing Consortium
Rusyn, I., Sakolish, C., Kato, Y., Stephan, C., Vergara, L., Hewitt, P., Bhaskaran, V., Davis, M., Hardwick, R. N., Ferguson, S. S., et al. (2022) · Toxicological Sciences · doi:10.1093/toxsci/kfac061 · Cited by 43
Self-citation
Metadata
- Authors
- Baltazar, M. T., Cable, S., Carmichael, P. L., Cubberley, R., Cull, T., Delagrange, M., Dent, M. P., Hatherell, S., Houghton, J., Kukic, P., Li, H., Lee, M.-Y., Malcomber, S., Middleton, A. M., Moxon, T. E., Nathanail, A. V., Nicol, B., Pendlington, R., Reynolds, G., Reynolds, J., White, A., & Westmoreland, C.
- Venue
- Toxicological Sciences
- Publisher
- Oxford University Press (OUP)
- Published
- 2020-04-10
- Volume
- 176
- Issue
- 1
- Pages
- 236-252
- ISSN
- 1096-0929 (ISSN-L)
- 1096-6080
- OpenAlex
- W3016186875
- Cited by
- 151
- References
- 10
- FWCI
- 12.75
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.